Gary Bloomgren

2.9k total citations · 1 hit paper
17 papers, 2.1k citations indexed

About

Gary Bloomgren is a scholar working on Oncology, Electrical and Electronic Engineering and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gary Bloomgren has authored 17 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Electrical and Electronic Engineering and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gary Bloomgren's work include Polyomavirus and related diseases (9 papers), Full-Duplex Wireless Communications (6 papers) and Multiple Sclerosis Research Studies (4 papers). Gary Bloomgren is often cited by papers focused on Polyomavirus and related diseases (9 papers), Full-Duplex Wireless Communications (6 papers) and Multiple Sclerosis Research Studies (4 papers). Gary Bloomgren collaborates with scholars based in United States, Germany and Netherlands. Gary Bloomgren's co-authors include Sandra Richman, Meena Subramanyam, Tatiana Plavina, Carmen Bozic, Rebecca Noel, Daniel Braun, Sophia Lee, Alfred Sandrock, Ruth E. Patterson and James Scanlon and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Neurology.

In The Last Decade

Gary Bloomgren

16 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

2012 878 citations Gary Bloomgren, Sandra Richman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Bloomgren United States	12	1.1k	930	425	407	396	17	2.1k
James Scanlon United States	9	594 0.5×	573 0.6×	350 0.8×	231 0.6×	64 0.2×	14	1.4k
Barry Ticho United States	14	418 0.4×	449 0.5×	33 0.1×	132 0.3×	64 0.2×	27	1.5k
Tadaoki Morimoto Japan	21	522 0.5×	360 0.4×	116 0.3×	148 0.4×	269 0.7×	86	1.4k
Gaye Hafez United States	19	480 0.4×	139 0.1×	38 0.1×	86 0.2×	317 0.8×	59	1.1k
Woo Chan Park South Korea	25	359 0.3×	185 0.2×	585 1.4×	16 0.0×	634 1.6×	163	2.4k
Michael Scordo United States	17	834 0.7×	229 0.2×	35 0.1×	140 0.3×	21 0.1×	120	1.3k
Andreas Wolf Germany	22	1.5k 1.3×	310 0.3×	38 0.1×	25 0.1×	162 0.4×	40	2.6k
JC Lee United States	14	242 0.2×	201 0.2×	35 0.1×	51 0.1×	82 0.2×	36	846
Annalisa Rossi Italy	21	305 0.3×	128 0.1×	167 0.4×	13 0.0×	175 0.4×	43	1.5k
Petra W. Duda United States	18	618 0.5×	844 0.9×	6 0.0×	127 0.3×	55 0.1×	38	1.6k

Countries citing papers authored by Gary Bloomgren

Since Specialization

Citations

This map shows the geographic impact of Gary Bloomgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bloomgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bloomgren more than expected).

Fields of papers citing papers by Gary Bloomgren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Bloomgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bloomgren. The network helps show where Gary Bloomgren may publish in the future.

Co-authorship network of co-authors of Gary Bloomgren

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Bloomgren. A scholar is included among the top collaborators of Gary Bloomgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Bloomgren. Gary Bloomgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Jain, Priya, Rose Marino, Madé Wenten, et al.. (2020). Evaluation of Opioid Overdose Reports in Patients Treated with Extended-Release Naltrexone: Postmarketing Data from 2006 to 2018. Drug Safety. 44(3). 351–359. 4 indexed citations

Richman, Sandra, et al.. (2016). Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study. BMC Neurology. 16(1). 150–150. 84 indexed citations

Dong‐Si, Tuan, Sarah Gheuens, Madé Wenten, et al.. (2015). Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy. Journal of NeuroVirology. 21(6). 637–644. 75 indexed citations

Plavina, Tatiana, Meena Subramanyam, Gary Bloomgren, et al.. (2014). Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy. Annals of Neurology. 76(6). 802–812. 306 indexed citations

Dong‐Si, Tuan, Sandra Richman, Mike P. Wattjes, et al.. (2014). Outcome and survival of asymptomatic PML in natalizumab‐treated MS patients. Annals of Clinical and Translational Neurology. 1(10). 755–764. 90 indexed citations

Cristiano, Lynda M., et al.. (2013). Evaluation of Pregnancy Outcomes from the TYSABRI® (Natalizumab) Pregnancy Exposure Registry (P02.127). Neurology. 80(7_supplement). 20 indexed citations

Wenten, Madé, Mohamed Hussein, E.M. Pelletier, et al.. (2012). Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti‐diabetic medication: a follow‐up study. Diabetic Medicine. 29(11). 1412–1418. 64 indexed citations

Bloomgren, Gary, Sandra Richman, Christophe Hotermans, et al.. (2012). Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. New England Journal of Medicine. 366(20). 1870–1880. 878 indexed citations breakdown →

Cristiano, Lynda M., et al.. (2012). Natalizumab Use in Patients With Crohnʼs Disease (CD) and Relapsing Multiple Sclerosis (MS): Updated Utilization and Safety Results. Inflammatory Bowel Diseases. 18. S67–S67. 2 indexed citations

10.

Bloomgren, Gary, Sandra Richman, Christophe Hotermans, et al.. (2012). Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy. Survey of Anesthesiology. 56(6). 329–330. 8 indexed citations

11.

Varghese, Santosh T., Gary S. Hogge, Gary Bloomgren, et al.. (2012). Mo1050 Natalizumab use in Patients With Crohn's Disease and Relapsing Multiple Sclerosis: Updated Utilization and Safety Results From the Touch(r) Prescribing Program, the Pregnancy Registry, and the INFORM and TYGRIS Studies. Gastroenterology. 142(5). S–581.

12.

Bozic, Carmen, Sandra Richman, Tatiana Plavina, et al.. (2012). Anti-JCV Antibody Prevalence in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-2 (S41.002). Neurology. 78(Meeting Abstracts 1). S41.002–S41.002. 11 indexed citations

13.

Dong‐Si, Tuan, Nancy Richert, J. A. Barnard, et al.. (2012). Classification of Natalizumab Cases with Progressive Multifocal Leukoencephalopathy (P07.058). Neurology. 78(Meeting Abstracts 1). P07.058–P07.058. 4 indexed citations

14.

Bozic, Carmen, Sandra Richman, Tatiana Plavina, et al.. (2011). Anti‐John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY‐1. Annals of Neurology. 70(5). 742–750. 102 indexed citations

15.

Dore, David D., Gary Bloomgren, Madé Wenten, et al.. (2011). A cohort study of acute pancreatitis in relation to exenatide use. Diabetes Obesity and Metabolism. 13(6). 559–566. 116 indexed citations

16.

Noel, Rebecca, Daniel Braun, Ruth E. Patterson, & Gary Bloomgren. (2009). Increased Risk of Acute Pancreatitis and Biliary Disease Observed in Patients With Type 2 Diabetes. Diabetes Care. 32(5). 834–838. 349 indexed citations

17.

Noel, Rebecca, Daniel Braun, Ruth E. Patterson, & Gary Bloomgren. (2008). INCREASED RISK OF ACUTE PANCREATITIS OBSERVED IN PATIENTS WITH TYPE 2 DIABETES. Pancreas. 37(4). 487–487. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact